Načítá se...
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance
The efficacy of triple therapy for Helicobacter pylori infection has dramatically declined over the last decade, largely related to increasing clarithromycin resistance rates. From a microbiological standpoint, bismuth quadruple therapy is the ideal replacement since it combines drugs for which resi...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4130841/ https://ncbi.nlm.nih.gov/pubmed/25132750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i30.10338 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|